Dis-Chem Pharmacies Limited (JSE:DCP)
South Africa · Delayed Price · Currency is ZAR · Price in ZAc | Market Cap | 20.91B -29.3% |
| Revenue (ttm) | 44.53B +8.9% |
| Net Income | 894.57M -27.6% |
| EPS | 1.04 -27.5% |
| Shares Out | 856.11M |
| PE Ratio | 23.40 |
| Forward PE | 17.23 |
| Dividend | 0.45 (1.86%) |
| Ex-Dividend Date | Nov 18, 2026 |
| Volume | 3,435,233 |
| Open | 2,486.00 |
| Previous Close | 2,520.00 |
| Day's Range | 2,442.00 - 2,579.00 |
| 52-Week Range | 2,402.00 - 3,900.00 |
| Beta | 0.35 |
| Analysts | Hold |
| Price Target | 2,882.86 (+18.05%) |
| Earnings Date | Oct 29, 2026 |
About Dis-Chem Pharmacies
Dis-Chem Pharmacies Limited, together with its subsidiaries, engages in the retail and wholesale of healthcare products and pharmaceuticals in South Africa. The company operates through two segments: Retail and Wholesale. It owns and operates a chain of retail stores that offers various products, including dispensaries, personal care and beauty, healthcare and nutrition, baby care, and other products. The company also provides pharmaceutical, health, and front shop products in the wholesale market, health insurance products, occupational health... [Read more]
Financial Performance
In fiscal year 2026, Dis-Chem Pharmacies's revenue was 42.83 billion, an increase of 9.33% compared to the previous year's 39.17 billion. Earnings were 978.89 million, a decrease of -17.03%.
Financial StatementsAnalyst Summary
According to 7 analysts, the average rating for DCP stock is "Hold." The 12-month stock price target is ZAC 2,883, which is an increase of 18.05% from the latest price.
News
Dis-Chem Pharmacies Earnings Call Transcript: H1 2027
H1 revenue grew 8%, but operating profit fell 10.5% as investment and costs rose. Better Rewards drove market-share gains and retail margin expansion; management expects H2 margin recovery amid soft markets and SEP pressures.
Dis-Chem Pharmacies Quarterly report: H1 2027
Dis-Chem Pharmacies has published its H1 2027 quarterly earnings report on October 30, 2026.
Dis-Chem Pharmacies Slides: H1 2027
Dis-Chem Pharmacies has posted slides in relation to its H1 2027 quarterly earnings report, which was published on October 30, 2026.
Dis-Chem Pharmacies Earnings release: H1 2027
Dis-Chem Pharmacies released its H1 2027 earnings on October 30, 2026, summarizing the period's financial results.
Dis-Chem Pharmacies Transcript: AGM 2026
Strong revenue and market share growth were achieved through ecosystem investments, the launch of Better Rewards, and the Store of the Future. Despite a decline in operating profit due to non-recurring costs, core retail and wholesale segments showed robust performance, with strategic restructuring and digital innovation set to drive future growth.
Dis-Chem Pharmacies Earnings Call Transcript: H2 2026
Better Rewards and digital transformation drove strong revenue and market share gains, with total income margin improving despite significant ecosystem investment and restructuring. Retail and wholesale segments both grew, and the Store of the Future format is set to accelerate expansion.
Dis-Chem Pharmacies Annual report: H2 2026
Dis-Chem Pharmacies has published its H2 2026 annual report on May 29, 2026.
Dis-Chem Pharmacies Annual report: H2 2026
Dis-Chem Pharmacies has published its H2 2026 annual report on May 29, 2026.
Dis-Chem Pharmacies Slides: H2 2026
Dis-Chem Pharmacies has posted slides in relation to its H2 2026 quarterly earnings report, which was published on May 29, 2026.
Dis-Chem versus Clicks
South Africa’s two largest pharmacy chains, Dis-Chem and Clicks, are fighting for market share. Here is the scoreboard.